U.S. Pharmaceutical Preparation Market. Analysis and Forecast to 2030
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingU.S.: Pharmaceutical Preparation Market 2024
Pharmaceutical Preparation Market Size in the U.S.
For the fourth consecutive year, the U.S. pharmaceutical preparation market recorded growth in sales value, which increased by X% to $X in 2023. Overall, the total consumption indicated buoyant growth from 2013 to 2023: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption increased by X% against 2019 indices. Over the period under review, the market attained the peak level in 2023 and is likely to continue growth in the near future.
Pharmaceutical Preparation Production in the U.S.
In value terms, pharmaceutical preparation production declined to $X in 2023. The total output value increased at an average annual rate of X% over the period from 2013 to 2023; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth was the most pronounced in 2014 when the production volume increased by X%. Pharmaceutical preparation production peaked at $X in 2022, and then dropped in the following year.
Join Us at HANNOVER MESSE 2024
Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany
Pharmaceutical Preparation Exports
Exports from the U.S.
In 2023, approx. X tons of pharmaceutical preparations were exported from the United States; shrinking by X% on the year before. In general, exports saw a perceptible reduction. The growth pace was the most rapid in 2018 with an increase of X%. As a result, the exports reached the peak of X tons. From 2019 to 2023, the growth of the exports failed to regain momentum.
In value terms, pharmaceutical preparation exports expanded sharply to $X in 2023. Overall, total exports indicated moderate growth from 2013 to 2023: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, exports increased by X% against 2017 indices. The growth pace was the most rapid in 2022 with an increase of X%. Over the period under review, the exports reached the maximum in 2023 and are expected to retain growth in the near future.
Exports by Country
Canada (X tons), Belgium (X tons) and the Netherlands (X tons) were the main destinations of pharmaceutical preparation exports from the United States, with a combined X% share of total exports.
From 2013 to 2023, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by the Netherlands (with a CAGR of X%), while the other leaders experienced more modest paces of growth.
In value terms, the largest markets for pharmaceutical preparation exported from the United States were China ($X), the UK ($X) and Japan ($X), together accounting for X% of total exports.
In terms of the main countries of destination, China, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The average pharmaceutical preparation export price stood at $X per ton in 2023, jumping by X% against the previous year. In general, the export price saw strong growth. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to Venezuela ($X per ton) was amongst the lowest.
From 2013 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to South Korea (X%), while the prices for the other major destinations experienced more modest paces of growth.
Pharmaceutical Preparation Imports
Imports into the U.S.
In 2023, after three years of growth, there was decline in supplies from abroad of pharmaceutical preparations, when their volume decreased by X% to X tons. Over the period under review, total imports indicated resilient growth from 2013 to 2023: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, imports increased by X% against 2013 indices. The growth pace was the most rapid in 2020 when imports increased by X% against the previous year. Imports peaked at X tons in 2022, and then reduced slightly in the following year.
In value terms, pharmaceutical preparation imports dropped to $X in 2023. In general, total imports indicated resilient growth from 2013 to 2023: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, imports increased by X% against 2017 indices. The most prominent rate of growth was recorded in 2015 with an increase of X% against the previous year. Over the period under review, imports reached the peak figure at $X in 2022, and then fell slightly in the following year.
Imports by Country
Mexico (X tons), India (X tons) and China (X tons) were the main suppliers of pharmaceutical preparation imports to the United States, together comprising X% of total imports.
From 2013 to 2023, the biggest increases were recorded for Mexico (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, Ireland ($X) constituted the largest supplier of pharmaceutical preparations to the United States, comprising X% of total imports. The second position in the ranking was taken by India ($X), with a X% share of total imports. It was followed by Switzerland, with a X% share.
From 2013 to 2023, the average annual growth rate of value from Ireland stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: India (X% per year) and Switzerland (X% per year).
Import Prices by Country
The average pharmaceutical preparation import price stood at $X per ton in 2023, approximately mirroring the previous year. In general, the import price continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2019 an increase of X%. As a result, import price reached the peak level of $X per ton. From 2020 to 2023, the average import prices remained at a somewhat lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was Ireland ($X,458 per ton), while the price for Mexico ($X per ton) was amongst the lowest.
From 2013 to 2023, the most notable rate of growth in terms of prices was attained by China (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the pharmaceutical preparation market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- NAICS 325412 - Pharmaceutical preparation manufacturing
Companies mentioned:
- Pfizer Inc.
- Merck & Co.
- Abbott Laboratories
- Abbvie Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Genentech
- Baxter International
- Allergan
- Biogen, Glaxosmithkline
- Celgene Corporation
- Hospira
- Alere
- Perrigo Company
- Mylan Inc.
- Regeneron Pharmaceuticals
- Novartis Corporation
- Alexion Pharmaceuticals
- Genzyme Corporation
- Zoetis
- Sanofi US Services
- Olympus Partners
- Valeant Pharmaceuticals International
- Merck Sharp & Dohme Corp.
- Glaxosmithkline Holdings (Americas)
- Wyeth
- Astrazeneca Pharmaceuticals
- Actavis Inc.
- Alcon Laboratories Holding Corporation
- Roche Holdings
Country coverage:
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023